Management of Perisplenic Varices in Portal Hypertension
Perisplenic varices associated with portal hypertension should be managed based on whether they are actively bleeding, with treatment decisions guided by cross-sectional imaging to determine vascular anatomy and the presence of portosystemic shunts, followed by multidisciplinary discussion between gastroenterology/hepatology and interventional radiology to select definitive therapy.
Initial Assessment and Imaging
When perisplenic varices are identified in the context of portal hypertension, obtain contrast-enhanced CT or MRI with portal venous phase imaging to map the complete vascular anatomy 1. This imaging is critical to identify:
- Presence and size of gastrorenal shunts
- Splenic vein patency versus occlusion
- Portal vein patency
- Inflow sources to the varices
- Other portosystemic collaterals
The vascular anatomy determines which treatment options are technically feasible and most appropriate 1, 2.
Management Based on Clinical Presentation
Non-Bleeding Perisplenic Varices
For incidentally discovered perisplenic varices without bleeding history:
- No specific prophylactic intervention is recommended solely for perisplenic varices 1
- Focus on managing underlying portal hypertension with non-selective beta-blockers if clinically significant portal hypertension is present
- Monitor for development of gastric or esophageal varices that may require prophylaxis
Bleeding Perisplenic Varices
If perisplenic varices are bleeding or associated with bleeding gastric varices:
Initial stabilization follows standard portal hypertensive bleeding protocols 1:
- Vasoactive drugs (octreotide or terlipressin)
- Antibiotic prophylaxis
- Restrictive transfusion strategy
- Endoscopic evaluation to identify bleeding source
Definitive treatment selection depends on vascular anatomy 1, 2:
If Gastrorenal Shunt is Present:
- BRTO (balloon-occluded retrograde transvenous obliteration) is optimal when local expertise exists and severe comorbid portal hypertension complications are absent 1
- Perform short-interval (48-hour) endoscopy post-BRTO to confirm vascular flow obliteration 1
- Add cyanoacrylate injection if residual flow detected 1
- Important caveat: BRTO increases portal pressure and may worsen esophageal varices, requiring surveillance endoscopy 1, 2
If No Suitable Gastrorenal Shunt or Significant Portal Hypertension Complications:
- TIPS placement with endovascular sclerosis/embolization of varices when feasible 1, 2
- TIPS addresses underlying portal hypertension and reduces rebleeding risk
- Covered stents are standard of practice 2
If Splenic Vein Occlusion is Present:
This represents a distinct entity (sinistral/left-sided portal hypertension) requiring different management 2:
- Partial splenic embolization is highly effective (100% success in controlling bleeding) 2
- Splenectomy is definitive treatment (100% success, no rebleeding) 2
- Splenic vein recanalization with angioplasty/stenting addresses the underlying cause 2
- Endoscopic therapy has poor success (only 40% hemostasis rate) and carries risk of exsanguination 2
Post-Treatment Surveillance
After successful treatment:
- Cross-sectional imaging at 4-6 weeks to confirm variceal obliteration and assess for vascular complications 1
- Endoscopic surveillance for esophageal varices, particularly after BRTO which increases portal pressure 1, 2
- Continue non-selective beta-blockers for portal hypertension management
Critical Decision Points
The key algorithmic approach is:
- Obtain vascular imaging first - this determines all subsequent treatment options
- Assess for splenic vein occlusion - if present, this fundamentally changes management toward splenic-directed therapy
- Identify gastrorenal shunt - if present and patient suitable, BRTO is preferred
- Evaluate severity of portal hypertension - high MELD scores or severe complications favor TIPS over BRTO
- Consider local expertise - transfer to tertiary center if complex vascular anatomy or specialized procedures needed 1
Common pitfall: Treating perisplenic varices without imaging assessment of vascular anatomy leads to inappropriate therapy selection and treatment failure. Always obtain cross-sectional imaging before definitive intervention 1, 2.